We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byBradley Cobbins
Modified over 2 years ago
Dichotomous estimation of prostate gland volume to inform treatment for benign prostatic hyperplasia: a prospective diagnostic study of the accuracy of digital rectal examination Introduction Accurate estimation of prostate size on DRE is an important tool for assessing risk of progression to benign prostatic hyperplasia and selection for 5-alpha reductase inhibitor (5- ARI) therapy. Previous studies have shown that despite underestimation of TRUS measured volumes DRE estimates have a role in distinguishing sizes larger than a given cutpoint 1. Recent investigations have demonstrated the high positive predictive value of DRE when used to identify patients with volumes greater than 30cc and were suitable for 5-ARI therapy 2. Conclusions DRE is a reliable tool for dichotomous assessment of prostatic volumes above 30 and 50cc. These results illustrate the value of re-examining the role of categorical DRE estimations in BPH patients. Results Patient characteristics Our population base presented for investigation of LUTS and biopsy. Patients that agreed to participate in this procedure had a range of characteristics displayed in Table 1. Table 1: Study population characteristics The high average PSA level was consistent with the large proportion of patients who presented for suspected prostate cancer. Figure 1: Diagnostic score values for three separate cut-offs At a 50cc cut-off positive predictive value was 81.1% (95%CI 73.3 – 87.4) compared to 94.3% (95%CI 90.6 – 96.8) for 30cc cut-off estimates. Specificity improved when estimating sizes greater than 50cc (84.76%, 95%CI ) compared to 30cc (76.27%, 95%CI 78.3 – 89.9). Mean PSA level (microg/L) for prostates less than 50cc (6.27) and more than 50cc (11.82) was comparable to grade 0-1 (6.89) and grade 2-3 (11.57) estimations. Figure 2: ROC curves with area under curve calculations Methods Patient selection A total of 303 patients presenting to a single tertiary centre practice were prospectively recruited between January 2010 and August Measurements Patients were examined by either a urologist or senior urology trainee. Each patient was graded to one of four groups: 100cc. These results were compared to gold-standard TRUS volume measurements based on three dimensional measurements (transverse, anterior-posterior and sagittal length). Patients also had WHO International Prostate Symptoms Score (IPSS) and serum total PSA levels measured prospectively. Outcomes Primary outcome was positive predictive value and specificity of DRE measurements for greater or less than 50cc. Secondary outcomes were positive predictive value and specificity of DRE measurements at a 30cc cut-off and mean serum PSA levels for each group. Analysis Diagnostic performance tests and receiver operator curves were calculated using SPSS © Version 20 GradPack software. ROC curves were summarised by discriminative ability and pairwise testing by the DeLong test. Acknowledgements Dr Lenaghan and A/Prof Woo for their rigorous efforts in patient collection, study design and invaluable guidance throughout this project. Aim The following study was designed to examine the reliability of DRE as a simple, minimally invasive and cost-effective tool to provide guidance for clinicians on differentiating between set prostate volume thresholds and to compare its performance to the gold standard TRUS measurements for patients presenting with LUTS. References 1. Roehrborn CG, Girman CJ, Rhodes T, Hanson KA, Collins GN, Sech SM, et al. Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology Apr;49(4): Ahmad S, Manecksha RP, Cullen IM, Flynn RJ, McDermott TE, Grainger R, et al. Estimation of clinically significant prostate volumes by digital rectal examination: a comparative prospective study. Can J Urol Dec;18(6): Michael Su 1, Daniel Lenaghan 2 & A/Prof Henry Woo 3 1 Westmead Hospital, Sydney, 2 Liverpool Hospital, Sydney, 3 Sydney Adventist Hospital, Sydney Poster presentation sponsor No. 093 Average Age (years)64.90 (34-89) Average IPSS11.86 (0-35) Average QL score2.53 (0-12) Average PSA8.78 (0-140)
J. Dahm 1, J. Ponsford 1,2, D. Wong 1,3, M.Schönberger 1,2 1 Monash University, 2 Monash-Epworth Rehabilitation Research Centre, 3 Epworth Hospital Introduction.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Magnetic resonance imaging detects significant prostate cancer and could be used to reduce unnecessary biopsies: Initial results from a prospective trial.
MODULE 3 1/113 Module 3: Treatment of BPH J. Curtis Nickel, MD, FRCSC Program Chair, Chief Editor Professor of Urology, Department of Urology Queens University.
2011 FRANKLIN COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=332.
Chapter 12 Static Equilibrium; Elasticity and Fracture Physics for Scientists & Engineers, 3 rd Edition Douglas C. Giancoli © Prentice Hall.
2011 WINNISQUAM COMMUNITY SURVEY YOUTH RISK BEHAVIOR GRADES 9-12 STUDENTS=1021.
Simulations The basics for simulations. Simulation is a way to model random events, such that simulated outcomes closely match real-world outcomes. By.
Diffusion-Weighted Imaging in Magnetic Resonance Imaging for prostate gland in Malaysian males with high prostate specific antigen in the diagnosis of.
Medical Therapy of Prostate Symptoms (MTOPS) Jeannette Y. Lee, Ph.D. University of Alabama at Birmingham.
بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.
Prof Stephen Langley Professor of Urology St Luke’s Cancer Centre, Guildford, UK PGMS, University of Surrey Focal Brachytherapy UK experience.
Slide 1 Effect of Combination Therapy with PROSCAR ™† (finasteride, MSD) and Doxazosin on the Risk of Clinical Progression of BPH by Total Baseline Prostate.
Prostate Cancer What a GP Needs to Know Dr Manish Patel Urological Cancer Surgeon Sydney Adventist Hospital Sydney Adventist Hospital Westmead Public and.
I 1. can 2 see 3 A 4 to 5 come 6 my 7 the 8.
Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.
Figure 1. Gross specimen of prostate gland.. Figure 2. Microscopic effects of BPH.
FT in diagnostic of HBV Prognostic Value of FibroTest in HCV Ngo et al, ClinChem 2006 A Prospective Analysis of the prognostic value of biomarkers (FirboTest)
Should I have that blood test for Prostate Cancer?
PSA: FACT OR FICTION THE DEBATE AS IT STANDS Dr Charles Chabert.
The PCA3 Assay improves the prediction of initial biopsy outcome and may be indicative of prostate cancer aggressiveness de la Taille A, Irani J, Graefen.
Advances in the Management of BPH Mr C Dawson Consultant Urologist Edith Cavell Hospital Peterborough.
AGVISE Laboratories %Zone or Grid Samples – Northwood laboratory % Grid or Zone Samples Tested Compared To Conventional Whole Field Composite.
Números. Practicar 1,2,3,4,5,6,7,8,9,10 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21 2, 4, 6, 8, 10, 12, 14, 16, 18, 20.
RISK OF NON SIGNIFICANT PROSTATE CANCER IN PROSTATE CANCER PATIENTS DIAGNOSED BY AN EXTENDED PROSTATE NEEDLE BIOPSY PROCEDURE AND TREATED BY RADICAL PROSTATECTOMY.
MODULE 5 1/33 Case 5: Sam. MODULE 5 Case 5: Sam 2/33 Patient History Sam is a 66 year old retired painter & construction worker. He is distressed.
EuroCondens SGB E. Elementy obudowy kotła
LUTS Shawket Alkhayal Consultant Urological Surgeon Benenden Hospital Tunbridge Wells Nuffield Hospital.
Between-Method Differences in Prostate Specific Antigen Assays Affect Prostate Cancer Risk Prediction by Nomograms C. Stephan, K. Siemβen, H. Cammann,
Urology Update Sanofi- Aventis Kenneth Lim, D.O. Urology Residency Director POH/ Detroit Medical Center.
MODULE 5 1/24 Case 7: John. MODULE 5 Case 7: John 2/24 Patient History John is a 64-year old retired school teacher. You recently sent him to see.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
2.10% more children born Die 0.2 years sooner Spend 95.53% less money on health care No class divide 60.84% less electricity 84.40% less oil.
Introduction Embedded Universal Tools and Online Features 2.
1-3 Frequency Tables and Stem-and-Leaf Plots Course 2 Warm Up Warm Up Problem of the Day Problem of the Day Lesson Presentation Lesson Presentation.
Moving to “T” National Instrument Institutional Trade Matching & Settlement Working Towards Successful Implementation Glenn MacPherson Program Director,
OAA Spring 2010 Grade 8 Reading Item Analysis. Informational Text (IT) A 17% B 10% C 3% D 69% (*) Reading Process (RP) A 6% B 1% C 5% D 88% (*) Informational.
EQUS Conference - Brussels, June 16, 2011 Ambros Uchtenhagen, Michael Schaub Minimum Quality Standards in the field of Drug Demand Reduction Parallel Session.
A Fractional Order (Proportional and Derivative) Motion Controller Design for A Class of Second-order Systems Center for Self-Organizing Intelligent Systems.
Department of Urology, Guangzhou First Municipal People’s Hospital, Guangzhou Medical College, Guangzhou, China Rubiao Ou, Meng You, Ping Tang, Hui Chen,
P.A.C.E.R. Progressive Aerobic Cardiovascular Endurance Run NJ Core Content Standards: 2.6 Fitness and Physical Activity.
Delivering clinical research to make patients, and the NHS, better Cancer Patients’ Experience of Research Findings and Opportunities From NCPES (National.
Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies J. Kaijser, T. Bourne, L. Valentin,
Prostate cancer Implementing NICE guidance 2008 NICE clinical guideline 58.
Contemporary practice of radiotherapy post radical prostatectomy at a tertiary referral centre in Australia Introduction Adverse features on histopathology.
Diagnostic Accuracy of Prostate Histoscaning (P005) Arumainayagam N 1, Mikhail M 1, Shamsuddin A 1, Nir D 2, Winkler M 1 1 Charing Cross Hospital, Imperial.
EVIDENCE ABOUT DIAGNOSTIC TESTS Min H. Huang, PT, PhD, NCS.
The Natural History of Benign Thyroid Nodules JAMA. 2015;313(9): doi: /jama Modulator Prof. 전숙 / R1 윤수진.
1 When you see… Find the zeros You think…. 2 To find the zeros...
Worksheets Demo 1 Demo 2 Demo 3 Demo 4.
© 2017 SlidePlayer.com Inc. All rights reserved.